| 2024-10-11 |
Taiwan nationwide study of first-line ALK-TKI therapy in ALK-positive lung adenocarcinoma |
Targeted Oncology. 2024 Oct 11;Article in Press. |
 |
| 2024-07-11 |
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study |
BMC Cancer. 2024 Jul 11;24:Article number 828. |
|
| 2023-10 |
Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer |
Lung Cancer. 2023 Oct;184:Article number 107357. |
|
| 2023-09 |
Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized study |
International Journal of Radiation Oncology Biology Physics. 2023 Sep 1;117(1):74-86. |
|
| 2023-04-25 |
Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study |
Scientific Reports. 2023 Apr 25;13:Article number 6727. |
|
| 2023-03-17 |
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naive ALK-positive advanced lung adenocarcinoma |
Frontiers in Oncology. 2023 Mar 17;13:Article number 1063695. |
|
| 2023-02-28 |
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma |
Frontiers in Oncology. 2023 Feb 28;13:Article number 1096683. |
|
| 2022-12-31 |
Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019 |
Viruses. 2022 Dec 31;15(1):Article number 126. |
|
| 2022-12 |
Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan |
Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218. |
|
| 2022-12 |
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer |
Annals of Oncology. 2022 Dec;33(12):1250-1268. |
|
| 2022-11-14 |
Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals |
Frontiers in Oncology. 2022 Nov 14;12:Article number 1019555. |
|
| 2022-09 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study |
European Journal of Cancer. 2022 Sep;173:123-132. |
|
| 2022-03-01 |
Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018 |
JAMA Network Open. 2022 Mar 1;5(3):Article number e224830. |
|
| 2022-02 |
Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps |
Annals of Surgical Oncology. 2022 Feb;29(2):1130-1140. |
|
| 2021-11-30 |
Survival outcomes of management in metastatic gastric adenocarcinoma patients |
Scientific Reports. 2021 Nov 30;11:Article number 23142. |
|
| 2021-05-26 |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis |
Oral Oncology. 2021 May 26;119:Article number 105358. |
|
| 2021-05-20 |
Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell lung cancer |
Cancers. 2021 May 20;13(10):Article number 2494. |
|
| 2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial |
Radiotherapy and Oncology. 2021 May;158:146-154. |
|
| 2021-02-04 |
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up |
Journal of Clinical Oncology. 2021 May;39(13):1448-1457. |
|
| 2020-07-01 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue |
Haematologica. 2020 Jul 1;105(7):e349-e354. |
|
| 2020-05 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas |
Oncologist. 2020 May;25(5):e782-e788. |
|
| 2020-02-18 |
Impacts of intralipid on nanodrug abraxane therapy and on the innate immune system |
Scientific Reports. 2020 Feb 18;10:Article number 2838. |
|
| 2020-01 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection |
Journal of the Formosan Medical Association = Taiwan Yi Zhi. 2020 Jan;119(1):335-344. |
|
| 2019-05 |
The relationship between air pollution and lung cancer in non-smokers in Taiwan |
Journal of Thoracic Oncology. 2019 May;14(5):784-792. |
|
| 2018-09 |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study |
Annals of Oncology. 2018 Sep;29(9):1972-1979. |
|
| 2018-09 |
Outcomes for cervical cancer patients treated with radiation in high-volume and low-volume hospitals |
International Journal of Radiation Oncology Biology Physics. 2018 Sep;102(1):184-193. |
|
| 2018-08 |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection |
Journal of Hepatology. 2018 Aug;69(2):286-292. |
|
| 2018-07 |
The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients |
Journal of the Chinese Medical Association. 2018 Jul;81(7):593-598. |
|
| 2018-07 |
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis |
Cancer Medicine. 2018 Jul;7(7):3073-3083. |
|
| 2018-03 |
Hospice exposure is associated with lower health care expenditures in Taiwanese cancer decedents' last year of life: A population-based retrospective cohort study |
Journal of Pain and Symptom Management. 2018 Mar;55(3):755-765.e5. |
|
| 2018-01-20 |
Patterns of age-specific socioeconomic inequalities in net survival for common cancers in Taiwan, a country with universal health coverage |
Cancer Epidemiology. 2018 Jan 20;53:42-48. |
|
| 2017-10-12 |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma |
Oncotarget. 2017 Oct 12;8(58):98384-98393. |
|
| 2017-07-27 |
The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: A nationwide Taiwanese cohort study |
Oncotarget. 2017 Jul 27;8(49):85203-85213. |
|
| 2017-07 |
Terminally Ill Taiwanese cancer patients’ and family caregivers’ agreement on patterns of life-sustaining treatment preferences is poor to fair and declines over a decade: Results from two independent cross-sectional studies |
Journal of Pain and Symptom Management. 2017 Jul;54(1):35-45.e4. |
|
| 2017-07 |
Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States-A smoothed Lexis diagram approach |
Cancer Medicine. 2017 Jul;6(7):1762-1775. |
|
| 2017-04 |
The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation |
International Journal of Cancer. 2017 Apr ;140(7):1662-1669. |
|
| 2017-04 |
Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas |
Oral Oncology. 2017 Apr;67:95-102. |
|
| 2017-04 |
Escalating health care expenditures in cancer decedents' last year of life: A decade of evidence from a retrospective population-based cohort study in Taiwan |
Oncologist. 2017 Apr;22(4):460-469. |
|
| 2017-03 |
Clinical outcomes of Taiwanese patients with cT4 oral cavity squamous cell carcinoma: Toward the identification of the optimal initial treatment approach for cT4b patients |
Annals of Surgical Oncology. 2017 Mar;24(3):785-793. |
|
| 2017-02 |
Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma |
European Journal of Cancer. 2017 Feb;72:226-234. |
|
| 2016-12 |
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer |
Oncotarget. 2016 Dec;7(52):85917-85928. |
|
| 2016-09 |
Trend in and correlates of undergoing radiotherapy in Taiwanese cancer patients' last month of life |
Journal of Pain and Symptom Management. 2016 Sep;52(3):395-403. |
|
| 2016-08 |
Characteristics and correlates of increasing use of surgery in Taiwanese cancer patients' last month of life, 2001-2010 |
Annals of Surgery. 2016 Aug;264(2):283-290. |
|
| 2016-07 |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status |
Oncotarget. 2016 Aug;7(29):46628-46635. |
|
| 2016-04 |
Receipt of life-sustaining treatments for Taiwanese pediatric patients who died of cancer in 2001 to 2010: A retrospective cohort study |
Medicine. 2016 Apr;95(16):Article number e3461. |
|
| 2016-01 |
S-1 with leucovorin for gastric cancer: How far can it go? |
Lancet Oncology. 2016 Jan;17(1):12-14. |
|
| 2016-01 |
A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial |
Medicine. 2016 Jan;95(3):Article number e2565. |
|
| 2015-12 |
Breast cancer quality of care in Taiwan in relation to hospital volume: A population-based cohort study |
Asia-Pacific Journal of Clinical Oncology. 2015 Dec;11(4):308-313. |
|
| 2015-12 |
A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer |
Journal of the National Comprehensive Cancer Network. 2015 Dec;13(12):1510-1518. |
|
| 2015-11 |
Determinants of hospital death for Taiwanese pediatric cancer decedents, 2001–2010 |
Journal of Pain and Symptom Management. 2015 Nov;50(5):685-692. |
|
